Anti-apoptotic effects of ruthenium nanozyme-augmented adipose stem cells accelerate cutaneous wound healing.

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

• Level A · Stronger Clinical Evidence
• Level B · Emerging clinical evidence with positive signals
• Level C · Early human research exploring benefits
• Level D · Scientific groundwork from lab and animal studies
• Emerging · Emerging topic under active research

Abstract (original English)

Introduction The failure of conventional therapies for diabetic wounds, including those relying solely on stem cells or antioxidants, stems from an inability to simultaneously overcome the hostile microenvironment characterized by chronic inflammation, excessive apoptosis, and impaired regeneration. Methods We developed a novel combinatorial platform, Ru@SVF, by integrating ruthenium nanozymes (RuNC) with a stromal vascular fraction gel (SVF-GEL). This design moves beyond simple material addition, aiming for synergy: RuNC provides potent reactive oxygen species (ROS) scavenging and anti-apoptotic signaling, while SVF-GEL ensures sustained release of pro-regenerative growth factors (VEGF, EGF, bFGF). After thorough physicochemical characterization and biocompatibility assessment, its mechanism and efficacy were evaluated in vitro and in a diabetic rat model. Results Ru@SVF exhibited excellent biocompatibility and superior functionality. In vitro, it not only robustly suppressed inflammation and mitochondrial apoptosis (via Bax/Bcl-2/Caspase-3,9 regulation) in HUVECs but also enhanced the secretion of key growth factors. In vivo, Ru@SVF treatment led to significantly accelerated wound closure, which was accompanied by reduced apoptosis, diminished inflammatory infiltration, and promoted angiogenesis, outperforming treatments with either RuNC or SVF-gel alone. Conclusion The Ru@SV

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.